ArticleScientific reports2021

Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific- and lipidation inhibitors in MEG-01 cells.

Etsuko Daimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.